Publications by authors named "Henning Cammann"

Claim this Profile
T
The percentage of prostate-specific antigen (PSA) isoform [-2]proPSA and the Prostate Health Index improve the diagnostic accuracy for clinically relevant prostate cancer at initial and repeat biopsy compared with total PSA and percentage free PSA in men aged ≤65 years.
Martin Boegemann, Carsten Stephan, Henning Cammann, Sébastien Vincendeau, Alain Houlgatte

BJU Int· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hormonal 'minipuberty' influences the somatic development of boys but not of girls up to the age of 6 years.
Marianne Becker, Klaus Oehler, Carl-Joachim Partsch, Ulrike Ulmen, Renate Schmutzler, Henning Cammann

Clin Endocrinol (Oxf)· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Re: Scott A. Tomlins, John R. Day, Robert J. Lonigro, et al. Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.04.039.
Carsten Stephan, Henning Cammann, Klaus Jung

Eur Urol· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk prediction models for biochemical recurrence after radical prostatectomy using prostate-specific antigen and Gleason score.
Xin-Hai Hu, Henning Cammann, Hellmuth-A Meyer, Klaus Jung, Hong-Biao Lu

Asian J Androl· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostate-Specific Antigen (PSA) Screening and New Biomarkers for Prostate Cancer (PCa).
Carsten Stephan, Harry Rittenhouse, Xinhai Hu, Henning Cammann, Klaus Jung

EJIFCC· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Artificial neural networks and prostate cancer--tools for diagnosis and management.
Xinhai Hu, Henning Cammann, Hellmuth-A Meyer, Kurt Miller, Klaus Jung

Nat Rev Urol· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative assessment of urinary prostate cancer antigen 3 and TMPRSS2:ERG gene fusion with the serum [-2]proprostate-specific antigen-based prostate health index for detection of prostate cancer.
Carsten Stephan, Klaus Jung, Axel Semjonow, Kai Schulze-Forster, Henning Cammann

Clin Chem· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter evaluation of [-2]proprostate-specific antigen and the prostate health index for detecting prostate cancer.
Carsten Stephan, Sébastien Vincendeau, Alain Houlgatte, Henning Cammann, Klaus Jung

Clin Chem· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
External validation of an artificial neural network and two nomograms for prostate cancer detection.
Thorsten H Ecke, Steffen Hallmann, Stefan Koch, Jürgen Ruttloff, Henning Cammann

ISRN Urol· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome prediction for prostate cancer detection rate with artificial neural network (ANN) in daily routine.
Thorsten H Ecke, Peter Bartel, Steffen Hallmann, Stefan Koch, Jürgen Ruttloff, Henning Cammann

Urol Oncol· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Avoiding pitfalls in applying prediction models, as illustrated by the example of prostate cancer diagnosis.
Henning Cammann, Klaus Jung, Hellmuth-A Meyer, Carsten Stephan

Clin Chem· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Between-method differences in prostate-specific antigen assays affect prostate cancer risk prediction by nomograms.
Carsten Stephan, Kerstin Siemssen, Henning Cammann, Frank Friedersdorff, Serdar Deger

Clin Chem· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Internal validation of an artificial neural network for prostate biopsy outcome.
Carsten Stephan, Henning Cammann, Martin Bender, Kurt Miller, Michael Lein

Int J Urol· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benign prostatic hyperplasia-associated free prostate-specific antigen improves detection of prostate cancer in an artificial neural network.
Carsten Stephan, Henning Cammann, Serdar Deger, Mark Schrader, Hellmuth A Meyer

Urology· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced serum selenoprotein P concentrations in German prostate cancer patients.
Hellmuth-Alexander Meyer, Birgit Hollenbach, Carsten Stephan, Tobias Endermann, Nils G Morgenthaler, Henning Cammann

Cancer Epidemiol Biomarkers Prev· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New markers and multivariate models for prostate cancer detection.
Carsten Stephan, Harry Rittenhouse, Henning Cammann, Michael Lein, Mark Schrader

Anticancer Res· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A [-2]proPSA-based artificial neural network significantly improves differentiation between prostate cancer and benign prostatic diseases.
Carsten Stephan, Anna-Maria Kahrs, Henning Cammann, Michael Lein, Mark Schrader

Prostate· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An artificial neural network for five different assay systems of prostate-specific antigen in prostate cancer diagnostics.
Carsten Stephan, Henning Cammann, Hellmuth-Alexander Meyer, Christian Müller, Serdar Deger

BJU Int· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Artificial neural network (ANN) velocity better identifies benign prostatic hyperplasia but not prostate cancer compared with PSA velocity.
Carsten Stephan, Nicola Büker, Henning Cammann, Hellmuth-Alexander Meyer, Michael Lein

BMC Urol· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Classification models for early detection of prostate cancer.
Joerg D Wichard, Henning Cammann, Carsten Stephan, Thomas Tolxdorff

J Biomed Biotechnol· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Re: Application of artificial intelligence to the management of urological cancer. M. F. Abbod, J. W. Catto, D. A. Linkens and F. C. Hamdy J Urol 2007; 178: 1150-1156.
Carsten Stephan, Henning Cammann, Michael Lein, Kurt Miller, Klaus Jung

J Urol· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of two different artificial neural networks for prostate biopsy indication in two different patient populations.
Carsten Stephan, Chuanliang Xu, Patrik Finne, Henning Cammann, Hellmuth-Alexander Meyer

Urology· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Re: Felix K.-H. Chun, Markus Graefen, Alberto Briganti, Andrea Gallina, Julia Hopp, Michael W. Kattan, Hartwig Huland and Pierre I. Karakiewicz. Initial biopsy outcome prediction--head-to-head comparison of a logistic regression-based nomogram versus artificial neural network. Eur Urol 2007;51:1236-43.
Carsten Stephan, Hellmuth-A Meyer, Henning Cammann, Michael Lein, Stefan A Loening

Eur Urol· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PSA and new biomarkers within multivariate models to improve early detection of prostate cancer.
Carsten Stephan, Henning Cammann, Hellmuth-A Meyer, Michael Lein, Klaus Jung

Cancer Lett· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assay-specific artificial neural networks for five different PSA assays and populations with PSA 2-10 ng/ml in 4,480 men.
Carsten Stephan, Chuanliang Xu, Henning Cammann, Markus Graefen, Alexander Haese

World J Urol· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis